Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

HIV can cause skin disorders, which are often the first sign of infection, especially in people with darker skin.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

TNF-alpha inhibitors can cause various immune-related skin issues.

The document concludes that skin and nail changes can indicate various underlying health conditions.

Cell death shapes skin stem cell environments, affecting inflammation, repair, and cancer.

The skin microbiome helps heal wounds and can be targeted to improve healing.

Non-white organ transplant patients have worse skin cancer outcomes due to later diagnosis and treatment.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Psychotropic medications can cause skin problems but also treat some skin conditions.

ceRNA networks offer potential treatments for skin aging and wound healing.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

Centrosomes are essential for healthy skin and hair growth, and their role is different from that of cilia.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The document describes skin diseases affecting the outer ear in dogs and cats, their spread to other body parts, and treatment options.

Skin reactions to antidepressants are common but usually not serious and can be treated.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Skin problems are very common in people with end-stage kidney disease.

Finasteride caused a rare skin rash in a man, which improved after stopping the medication.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

Skin stem cells remember past inflammation, helping them respond better to future injuries and possibly aiding in treating skin issues.

Elderly patients frequently suffer from skin conditions, especially inflammatory ones, highlighting the need for better healthcare.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Some patients taking antipsychotic medications experience skin reactions, ranging from mild to severe.